Healthcare -
Biotechnology - NYSE - US
$ 13.185
-1.46 %
$ 1.21 B
Market Cap
-4.13
P/E
RCUS - ACCOUNTS PAYABLE
Accounts Payable RCUS - Arcus Biosciences, Inc.
17 M
LAST VALUE
28.72%
2 YEAR CAGR
40.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR